Kurzporträt
Umsatz nach Geschäftsbereich
USD in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
---|---|---|---|---|---|
Pipeline Research and Development
100,0
%
| 1 | 100,0 % | 0 | 100,0 % | -44.99% |
Umsatz je Region
USD in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
---|---|---|---|---|---|
Belgium
100,0
%
| 1 | 100,0 % | 0 | 100,0 % | -44.99% |
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Stephen Stamp
CEO | Chief Executive Officer | 62 | 09.09.19 |
Dan Palmer
CTO | Chief Tech/Sci/R&D Officer | - | - |
Chief Tech/Sci/R&D Officer | 44 | 11.07.21 | |
Steve Ellul
PRN | Corporate Officer/Principal | - | 01.02.22 |
Fiona Sharp
AUD | Comptroller/Controller/Auditor | - | - |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Stephen Parker
CHM | Chairman | 65 | 20.06.22 |
Sijmen de Vries
BRD | Director/Board Member | 65 | 13.11.14 |
Stephen Stamp
CEO | Chief Executive Officer | 62 | 09.09.19 |
Simon Turton
BRD | Director/Board Member | 56 | 02.12.14 |
Ann Merchant
BRD | Director/Board Member | 59 | 31.12. |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 400 | 2 973 944 305 | 2 619 516 ( 0,0881 %) | 0 | 0,0881 % |
Unternehmenskontakt
Biodexa Pharmaceuticals Plc
1 Caspian Point Caspian Way
CF10 4DQ, Cardiff
+44 29 2048 0180
http://www.midatechpharma.comKonzerngesellschaften
Name | Kategorie und Branche |
---|---|
Midatech Pharma España SL
Midatech Pharma España SL Pharmaceuticals: MajorHealth Technology Part of Biodexa Pharmaceuticals Plc, Midatech Pharma España SL is a pharmaceutical company located in Spain. The Spanish company operates in the field of oncology and other areas. |
Pharmaceuticals: Major
|
Sektor
% 1. Jan. | Kap. | |
---|---|---|
+11.91% | 118 Mrd. | |
+11.60% | 106 Mrd. | |
-4.68% | 24.28 Mrd. | |
-0.82% | 21.96 Mrd. | |
-10.12% | 18.16 Mrd. | |
-42.12% | 16.37 Mrd. | |
-17.47% | 15.56 Mrd. | |
+2.77% | 13.63 Mrd. | |
+34.58% | 12.27 Mrd. |